These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 11736858)

  • 1. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
    Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Iwata R; Fujii T; Komemushi S; Ido T; Itoh M; Sasaki H; Watanabe T; Yanai K
    Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
    Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
    Tashiro M; Duan X; Kato M; Miyake M; Watanuki S; Ishikawa Y; Funaki Y; Iwata R; Itoh M; Yanai K
    Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Asakura M; Matsumura R; Itoh M
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.
    Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Fujii T; Komemushi S; Itoh M; Sasaki H; Watanabe T; Yanai K
    Br J Clin Pharmacol; 2002 Mar; 53(3):296-304. PubMed ID: 11874393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
    Farré M; Pérez-Mañá C; Papaseit E; Menoyo E; Pérez M; Martin S; Bullich S; Rojas S; Herance JR; Trampal C; Labeaga L; Valiente R
    Br J Clin Pharmacol; 2014 Nov; 78(5):970-80. PubMed ID: 24833043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional neuropharmacology in the human brain using positron emission tomography: PET imaging of impaired cognitive performance induced by sedative antihistamines].
    Yanai K; Okamura N; Itoh M; Watanabe T
    Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():48P-52P. PubMed ID: 10190133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical comparison of ebastine and other second generation H1-antihistamines.
    Yakuo I; Yabuuchi M; Ito T
    Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
    Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
    Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
    Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
    Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence for a lack of central effect of ebastine, an antihistaminic agent, in rats: a microdialysis study.
    Fujisaki Y; Itoh Y; Oishi R
    Jpn J Pharmacol; 2002 Dec; 90(4):353-6. PubMed ID: 12501012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio.
    Kubo N; Senda M; Ohsumi Y; Sakamoto S; Matsumoto K; Tashiro M; Okamura N; Yanai K
    Hum Psychopharmacol; 2011 Mar; 26(2):133-9. PubMed ID: 21433074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
    Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine.
    Okamura N; Yanai K; Higuchi M; Sakai J; Iwata R; Ido T; Sasaki H; Watanabe T; Itoh M
    Br J Pharmacol; 2000 Jan; 129(1):115-23. PubMed ID: 10694210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers.
    Sato H; Ito C; Hiraoka K; Tashiro M; Shibuya K; Funaki Y; Yoshikawa T; Iwata R; Matsuoka H; Yanai K
    Psychopharmacology (Berl); 2015 Oct; 232(19):3497-505. PubMed ID: 26146015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a sedative antihistamine, d-chlorpheniramine, on visuomotor spatial discrimination and regional brain activity as measured by positron emission tomography (PET).
    Mochizuki H; Tashiro M; Tagawa M; Kano M; Itoh M; Okamura N; Watanabe T; Yanai K
    Hum Psychopharmacol; 2002 Dec; 17(8):413-8. PubMed ID: 12457377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preclinical overview of ebastine. Studies on the pharmacological properties of a novel histamine H1 receptor antagonist.
    Roberts DJ
    Drugs; 1996; 52 Suppl 1():8-14. PubMed ID: 8828021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.